(The Center Square) – Eli Lilly and Company announced plans for a $3 billion expansion of the Kenosha facility that it bought in April. The expansion will be used to expand the medical supply company’s injectable manufacturing for diabetes, obesity and future medicines. The 84,000-square foot facility was completed for Nexus Pharmaceuticals in 2021 after […]
The post Eli Lilly announces $3B Kenosha facility expansion appeared first on The Black Chronicle.